Advancements in fourth-generation EGFR TKIs in EGFR-mutant NSCLC: Bridging biological insights and therapeutic development
Carla Corvaja, Antonio Passaro, Ilaria Attili, Pamela Trillo Aliaga, Gianluca Spitaleri, Ester Del Signore, Filippo de Marinis
Topics & Concepts
OsimertinibMedicineGefitinibLung cancerClinical trialDrug resistanceCancer researchT790MEpidermal growth factor receptorErlotinibDrug developmentCancerDrugPharmacologyOncologyInternal medicineBiologyGeneticsLung Cancer Treatments and MutationsCancer therapeutics and mechanismsQuinazolinone synthesis and applications